Blog

Scott Thacher: State cancer agency awards $89 million in grants to Texas institutions and companies

Scott Thacher/LinkedIn

Nov 25, 2024, 15:06

Scott Thacher: State cancer agency awards $89 million in grants to Texas institutions and companies

Scott Thacher, CEO and founder of Orphagen Pharmaceuticals, shared a post on LinkedIn:

“Texas calls.

The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that it plans to award Orphagen a $10.2 M product development grant over three years to partially fund the final steps towards IND filing and a Phase 1 clinical trial of OR-449, a novel therapeutic candidate for an intractable cancer, adrenocortical cancer (ACC). OR-449 may be developed subsequently in head and neck and lung squamous cancers as a therapy for the 3-10% of these tumors where its target is highly expressed.”

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Blog

OncoDaily

Blog

Scott Thacher: State cancer agency awards $89 million in grants to Texas institutions and companies